Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.5720
-0.0417 (-6.79%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Vivos Therapeutics Employees
Vivos Therapeutics had 270 employees as of March 31, 2026. The number of employees increased by 2 or 0.75% since the number was last reported on December 31, 2025.
Employees
270
Change
2
Growth
0.75%
Revenue / Employee
$72,474
Profits / Employee
-$92,548
Market Cap
7.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 270 | 2 | 0.75% | 270 | 0 |
| Dec 31, 2025 | 268 | 159 | 145.87% | 268 | 0 |
| Dec 31, 2024 | 109 | -14 | -11.38% | 109 | 0 |
| Dec 31, 2023 | 123 | -40 | -24.54% | 114 | 9 |
| Dec 31, 2022 | 163 | -4 | -2.40% | 154 | 9 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| VolitionRx | 75 |
| IceCure Medical | 69 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| enVVeno Medical | 33 |
| Sintx Technologies | 32 |
| Tenon Medical | 26 |
| HeartSciences | 15 |
VVOS News
- 3 days ago - Vivos Therapeutics intends to file registration statement for rights offering - TheFly
- 3 days ago - Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering - GlobeNewsWire
- 4 days ago - Vivos Therapeutics enters pact with South Palm Cardiovascular Associates - TheFly
- 4 days ago - Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients - GlobeNewsWire
- 5 days ago - Vivos Therapeutics Transcript: WTR Insights Conference: Powered by The Small Cap Showcase - Transcripts
- 5 days ago - Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026 - GlobeNewsWire
- 9 days ago - Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing - GlobeNewsWire
- 24 days ago - Vivos Therapeutics reports Q1 EPS (52c), consensus (45c) - TheFly